thiazoles has been researched along with sc 236 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ang, KK; Milas, L; Nakata, E; Newman, RA; Raju, U; Yang, P | 1 |
Bennett, PR; Sawdy, RJ; Sullivan, MH | 1 |
Choi, IY; Hong, SH; Jeong, HJ; Kim, HM; Kim, SJ; Lee, KM; Park, RK | 1 |
Finzer, P; Karl, T; Osswald, H; Rösl, F; Seibert, N; Stöhr, M | 1 |
Gao, W; Li, J; Lu, J; Morales, A; Xing, J | 1 |
5 other study(ies) available for thiazoles and sc 236
Article | Year |
---|---|
In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
Topics: Animals; Apoptosis; Cell Cycle; Cell Survival; Coloring Agents; Cyclin A; Cyclin A1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; DNA Damage; Drug Screening Assays, Antitumor; In Situ Nick-End Labeling; Isoenzymes; Mice; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; RNA, Messenger; Sulfonamides; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
The effects of non-steroidal anti-inflammatory compounds on human myometrial contractility.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Indomethacin; Isoenzymes; Meloxicam; Membrane Proteins; Myometrium; Organic Chemicals; Pregnancy; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Sulfonamides; Thiazines; Thiazoles; Uterine Contraction | 2003 |
Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase,
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Calcimycin; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Dual Specificity Phosphatase 1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Genes, Reporter; Humans; Immunohistochemistry; Ionophores; JNK Mitogen-Activated Protein Kinases; Luciferases; Mast Cells; Membrane Proteins; Microscopy, Confocal; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA; Stimulation, Chemical; Sulfonamides; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Thiazoles | 2005 |
Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Northern; Blotting, Western; Cell Cycle; Cyclins; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; G1 Phase; Gene Expression Regulation, Viral; HeLa Cells; Humans; Leupeptins; Meloxicam; Oncogene Proteins, Viral; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; S Phase; Sulfonamides; Sulindac; Thiazines; Thiazoles; Uterine Cervical Neoplasms | 2007 |
Muscle cyclo-oxygenase-2 pathway contributes to the exaggerated muscle mechanoreflex in rats with congestive heart failure.
Topics: Animals; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Heart Failure; Heart Rate; Kidney; Male; Membrane Proteins; Muscle Contraction; Muscle, Skeletal; Myocardial Infarction; Piperazines; Pyrazoles; Rats; Rats, Sprague-Dawley; Reflex, Stretch; Sulfonamides; Sympathetic Nervous System; Thiazoles | 2012 |